Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Patient Access Solutions, Inc. (PASO)
Plainview, NY, US
Patient Access Solutions, Inc. (PASO) specializes in providing comprehensive financial and administrative processing solutions tailored for the medical and dental sectors. Utilizing its proprietary merchant processing platform, the company facilitates essential services such as patient eligibility verification, streamlined medical billing, and flexible patient self-pay options. Beyond its core payment solutions, PASO offers a range of consultative and operational support, including detailed practice management assistance, strategic business consulting, thorough GAP analyses, and initiatives for marketing and practice development. The firm further diversifies its offerings with therapeutic interventions for conditions like autism, concussion, and PTSD, alongside other biomedical disorders, complemented by a suite of diagnostic testing services. Patient Access Solutions, Inc. is headquartered in Plainview, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +9,900.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | +0.00% | +0.00% | -98.53% | -99.71% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Healthcare Information Services: +14.2%-57.8%
-
EPS growth Medical - Healthcare Information Services: +43.1%+25.4%
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-5,511.2% Q1'22: +0.6%
-
EBIT margin Medical - Healthcare Information Services: +8.8%-5,698.1% Q1'22: +0.6%
-
ROIC Medical - Healthcare Information Services: +5.2%— Q1'22: -0.1%
-
Share dilution Medical - Healthcare Information Services: -0.1%+96.7%
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.08× Q1'22: 785.66×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bruce Weitzberg | Chairman, Chief Executive Officer & President | — | male |
| Donald A. Chiappetta | Chief Operating Officer of Medical Group | — | — |
| Gerald J. Desocio | Corporate Counsel | — | — |
| Joelle Vital | Chief Medical Officer | — | — |
| Robert Linzalone | Executive Vice President & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2020-11-24 | 2020-12-17 | James E. Banks | IN03 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-11 | 2020-10-06 | James E. Banks | IN03 | Self | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-09 | 2020-10-06 | James E. Banks | IN03 | Self | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-09-03 | 2020-10-06 | James E. Banks | IN03 | Self | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-02 | 2020-10-06 | James E. Banks | IN03 | Self | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-09-02 | 2020-10-06 | James E. Banks | IN03 | Self | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-01 | 2020-10-06 | James E. Banks | IN03 | Self | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-09-01 | 2020-10-06 | James E. Banks | IN03 | Self | Purchase | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PASO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
